Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
62,849.31 +3,139.89 (+5.26%) CMC Crypto 200
1,359.39 +82.41 (+6.45%)
Asahi Kasei Corporation (ASAA.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:05AM CEST
| Previous close | 6.45 |
| Open | 6.55 |
| Bid | 6.53 x 200000 |
| Ask | 6.86 x 200000 |
| Day's range | 6.55 - 6.55 |
| 52-week range | 5.68 - 7.06 |
| Volume | |
| Avg. volume | 141 |
| Market cap | 9.279B |
| Beta (5Y monthly) | 0.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.43 |
| Earnings date | 09 May 2024 |
| Forward dividend & yield | 0.22 (3.41%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | N/A |
Business WireAsahi Kasei Bioprocess to Unveil THESYS™ ACS ERGO Synthesis Column at TIDES USA
TOKYO & NEW YORK & DÜSSELDORF, Germany, May 02, 2024--Asahi Kasei Bioprocess' (AKB) THESYS™ ACS ERGO synthesis column will be on display and demonstrated at Booth 213 at TIDES USA 2024.
Business WireAsahi Kasei to Construct a Lithium-ion Battery Separator Plant in Canada
TOKYO & NEW YORK & DÜSSELDORF, Germany, April 25, 2024--Asahi Kasei plans to construct an integrated plant in Ontario, Canada for base film manufacturing and coating of Hipore™ wet-process LIB separator.
Business WireAsahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development
TOKYO & NEW YORK & DÜSSELDORF, Germany, April 11, 2024--Asahi Kasei Bioprocess (AKB) and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics.
© 2024 Yahoo. All rights reserved.